They reported that TAZ can enhance an invasive PCa phenotype by facilitating the interaction between E26 transformation-specific (ETS) transcription factors and the SH3 domain-binding protein 1 (SH3BP1). The gene discussed is SH3BP1; the disease is posterior cortical atrophy.